Theravance Biopharma, Inc.

Connor, Clark & Lunn Investment Management Ltd. TBPH

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/10/2026

Shares

221,662

Value ($000)

4,147

Weight

0.0%

2021 Q3 - 2025 Q4 (7 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/10/2026	4,147	0.0%	221,662	12/31/2025
2025 Q3	11/13/2025	2,553	0.0%	174,837	9/30/2025
2025 Q2	8/7/2025	624	0.0%	56,613	6/30/2025
2024 Q2	8/9/2024	136	0.0%	16,023	6/30/2024
2022 Q1	5/12/2022	387	0.0%	40,477	3/31/2022
2021 Q4	2/10/2022	365	0.0%	33,034	12/31/2021
2021 Q3	11/12/2021	327	0.0%	44,237	9/30/2021